Beta Bionics, Inc. Common Stock share price logo

Beta Bionics, Inc. Common Stock Share Price

NASDAQ: BBNX

Small Cap

$11.80

-0.47

(-3.83%)

Live

as on

Beta Bionics, Inc. Common Stock Stock Performance

as on April 23, 2026 at 3:07 am IST

  • Day's Low

    Day's High

    $10.89
    $12.99
    downward going graph

    7.71%

    Downside

    10.08%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.80
    $32.71
    downward going graph

    25.42%

    Downside

    177.20%

    Upside

    downward going graph

Beta Bionics, Inc. Common Stock share price movements today

Previous Close
$12.27
Open
$12.96
Volume
1.1M
Day's Low - High
$10.89 - $12.99
52 Week Low - High
$8.80 - $32.71

Beta Bionics, Inc. Common Stock Historical Returns

1 Month Return
+ 14.67 %
3 Month Return
-25.66 %
1 Year Return
+ 18.09 %
3 Year Return
0 %
5 Year Return
0 %

Beta Bionics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Beta Bionics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$575.3M

EPS (TTM)

-1.7725

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-40.26%

Beta Bionics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Bionics, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$575.3MNANA-73.02%
BUY$88.5B39.82%31.4914.44%
BUY$125.4B23.9%40.3112.92%
BUY$105.3B-36.85%23.7713.00%
BUY$46.3B-17.1%45.0317.69%

Stock Returns calculator for Beta Bionics, Inc. Common Stock Stock including INR - Dollar returns

The Beta Bionics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Beta Bionics, Inc. Common Stock investment value today

Current value as on today

₹1,25,030

Returns

₹25,030

(+25.03%)

Returns from Beta Bionics, Inc. Common Stock Stock

₹13,571 (+13.57%)

Dollar Impact

₹11,460 (+11.46%)

Beta Bionics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
3
8
12
15
16
20
17
23
27
32
Gross Profit
1
5
7
8
8
11
8
12
15
18
Operating Income
-8
-8
-9
-11
-10
-13
-18
-19
-17
-16
EBITDA
-8
-8
-8
-13
-10
-17
-18
-16
-13
-15
Interest Expense
-
0
-
-
-
0
-
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-18
-12
-14
-9
-18
-28
-16
-14
-13
Income Tax Expense
-
-
-
-
-
-
-
-
-
0
Net Income
-8
-18
-12
-14
-9
-18
-28
-16
-14
-13
Net Profit Margin
-280.63%
-225.72%
-96.26%
-96.13%
-58.28%
-88.59%
-162.46%
-72.59%
-52.14%
-41.92%

Beta Bionics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
11
65
100
Gross Profit
0
6
35
55
Operating Income
-65
-35
-45
-71
EBITDA
-63
-34
-44
-73
Interest Expense
0
0
-
-
Depreciation
2
2
2
2
Income Before Tax
-64
-44
-54
-73
Income Tax Expense
-
-
-
0
Net Income
-64
-44
-54
-73
Net Profit Margin
-36173.74%
-367.64%
-84.08%
-73.02%

Beta Bionics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-18
-12
-14
-9
-18
-28
-16
-14
-13
Operating Cash Flow
-6
-12
-12
-9
-14
-19
-13
-8
-8
Investing Cash Flow
-69
7
3
15
-29
-179
6
9
-
Financing Cash Flow
0
0
0
-1
56
211
0
2
1
Change in Cash
26
-4
-9
17
12
12
-7
3
-38

Beta Bionics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-44
-54
-73
Operating Cash Flow
-32
-48
-50
Investing Cash Flow
-69
-3
-
Financing Cash Flow
101
55
214
Change in Cash
-1
3
-30

Insights on Beta Bionics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BBNX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BBNX stock has moved down by -5.8%

About Beta Bionics, Inc. Common Stock

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.
OrganisationBeta Bionics, Inc. Common Stock
Headquarters11 Hughes, Irvine, CA, United States, 92618
IndustryMedical Devices
CEOMr. Sean T. Saint PE
E-voting on sharesClick here to vote

Key Management of Beta Bionics, Inc. Common Stock

Name

Title

Blake Beber

Head of Investor Relations

Mr. Kevin Meinert

Vice President of Legal & Business Development

Dr. Steven Russell M.D., Ph.D.

Chief Medical Officer

Mr. Mark Hopman M.B.A., R.Ph.

Chief Commercial Officer

Mr. Sean T. Saint PE

President, CEO & Director

Mr. Stephen H. Feider

CFO, Treasurer & Secretary

Mr. Mike Mensinger

Chief Product Officer

Mr. David Henderson

Vice President of Operations

FAQs

What is Beta Bionics, Inc. Common Stock share price today?

Beta Bionics, Inc. Common Stock share price today is $11.8 as on . Beta Bionics, Inc. Common Stock share today touched a day high of $12.99 and a low of $10.89.

What is the 52 week high and 52 week low for Beta Bionics, Inc. Common Stock share?

Beta Bionics, Inc. Common Stock share touched a 52 week high of $32.71 on and a 52 week low of $8.8 on . Beta Bionics, Inc. Common Stock stock price today i.e. is trending at $11.8,which is 63.93% down from its 52 week high and 34.09% up from its 52 week low.

What is Beta Bionics, Inc. Common Stock's market capitalisation today?

Beta Bionics, Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in Beta Bionics, Inc. Common Stock Stock (BBNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Beta Bionics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beta Bionics, Inc. Common Stock Shares that will get you 0.1271 shares as per Beta Bionics, Inc. Common Stock share price of $11.8 per share as on April 22, 2026 at 9:37 pm IST.

What is the minimum amount required to buy Beta Bionics, Inc. Common Stock Stock (BBNX) from India?

Indian investors can start investing in Beta Bionics, Inc. Common Stock (BBNX) shares with as little as ₹93.775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.75 in Beta Bionics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Beta Bionics, Inc. Common Stock share’s latest price of $11.8 as on April 22, 2026 at 9:37 pm IST, you will get 0.8475 shares of Beta Bionics, Inc. Common Stock. Learn more about fractional shares .